Sanofi (NASDAQ:SNY) will host a virtual scientific session
on Tuesday, June 16, at 8:00 am ET to present Phase 3 data on enzyme
replacement therapy avalglucosidase alfa in patients with late-onset
Pompe disease.
Pompe is
an inherited disorder caused by the buildup of glycogen in the body’s
cells due to mutations in the gene that codes for an enzyme called acid
alpha-glucosidase.
https://seekingalpha.com/news/3580997-sanofi-to-present-data-on-pompe-enzyme-replacement-therapy-june-16
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.